AVEO Pharmaceuticals Inc (AVEO) - Financial and Strategic SWOT Analysis Review

November 2021 | 53 pages | ID: A15430FA150EN
GlobalData

Abstracts

AVEO Pharmaceuticals Inc (AVEO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AVEO Pharmaceuticals Inc (AVEO), is a biopharmaceutical company that focuses on the discovery, development, and commercialization of drugs for the treatment of various types of cancers. Its flagship product tivozanib is approved as a first-line treatment for adult patients with renal cell carcinoma marketed under the brand name Fotivda in European Union, Iceland and Norway. The company’s clinical product includes Ficlatuzumab, a hepatocyte growth factor inhibitory antibody and AV-203, an anti-ErbB3 monoclonal antibody. It also has pre-clinical products in the pipeline. The company develops products through strategic partnerships with other pharmaceutical companies. AVEO is headquartered in Boston, Massachusetts, the US.

AVEO Pharmaceuticals Inc Key Recent Developments

Nov 08,2021: AVEO Oncology Reports Third Quarter 2021 Financial Results and Provides Business Update
Aug 27,2021: AVEO Pharmaceuticals announces senior management change
Aug 05,2021: AVEO Oncology Reports Second Quarter 2021 Financial Results and Provides Business Update
May 10,2021: AVEO Oncology Reports First Quarter 2021 Financial Results and Provides Business Update
Mar 23,2021: AVEO Announces Pricing of $48.0 Million Public Offering of Common Stock

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

AVEO Pharmaceuticals Inc - Key Facts
AVEO Pharmaceuticals Inc - Key Employees
AVEO Pharmaceuticals Inc - Key Employee Biographies
AVEO Pharmaceuticals Inc - Major Products and Services
AVEO Pharmaceuticals Inc - History
AVEO Pharmaceuticals Inc - Company Statement
AVEO Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
AVEO Pharmaceuticals Inc - Business Description
AVEO Pharmaceuticals Inc - Corporate Strategy
AVEO Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
AVEO Pharmaceuticals Inc - Strengths
AVEO Pharmaceuticals Inc - Weaknesses
AVEO Pharmaceuticals Inc - Opportunities
AVEO Pharmaceuticals Inc - Threats
AVEO Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
AVEO Pharmaceuticals Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Nov 08, 2021: AVEO Oncology Reports Third Quarter 2021 Financial Results and Provides Business Update
Aug 27, 2021: AVEO Pharmaceuticals announces senior management change
Aug 05, 2021: AVEO Oncology Reports Second Quarter 2021 Financial Results and Provides Business Update
May 10, 2021: AVEO Oncology Reports First Quarter 2021 Financial Results and Provides Business Update
Mar 16, 2021: AVEO Oncology Reports Full Year 2020 Financial Results and Provides Business Update
Mar 10, 2021: AVEO Announces Appointment of Mike Ferraresso to Chief Commercial Officer
Feb 18, 2021: AVEO Oncology Announces Participation at the 2021 SVB Leerink Global Healthcare Conference
Jan 21, 2021: AVEO Pharmaceuticals announces management change
Jan 07, 2021: AVEO Oncology highlights recent progress and 2021 outlook
Jan 06, 2021: AVEO Pharmaceuticals announces board change

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

AVEO Pharmaceuticals Inc, Key Facts
AVEO Pharmaceuticals Inc, Key Employees
AVEO Pharmaceuticals Inc, Key Employee Biographies
AVEO Pharmaceuticals Inc, Major Products and Services
AVEO Pharmaceuticals Inc, History
AVEO Pharmaceuticals Inc, Subsidiaries
AVEO Pharmaceuticals Inc, Key Competitors
AVEO Pharmaceuticals Inc, Ratios based on current share price
AVEO Pharmaceuticals Inc, Annual Ratios
AVEO Pharmaceuticals Inc, Annual Ratios (Cont...1)
AVEO Pharmaceuticals Inc, Interim Ratios
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
AVEO Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

AVEO Pharmaceuticals Inc, Performance Chart (2016 - 2020)
AVEO Pharmaceuticals Inc, Ratio Charts
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
AVEO Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021